Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage ...

TG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease relapse in patients with surgically resected HPV-negative head and neck squamous ...

The appraisal committee has prepared final draft guidance (FDG) on pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer [ID3907] and submitted it to NICE. The FDG has been sent ...